ClinicalTrials.gg
RecruitingNCT07426926Updated Sep 29, 2026

Home-Based Photobiomodulation Effects in the Postoperative Period of Distal Radius Fractures

An interventional study of Open reduction and internal fixation (ORIF) with locked volar plate and Home exercises in Distal Radius Fracture, sponsored by University of Nove de Julho. Recruiting at 1 site in Brazil. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by University of Nove de Julho · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.
Updated Sep 29, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This double-blind, randomized controlled clinical trial aims to evaluate the adjuvant effect of home-based photobiomodulation (PBM) therapy on the rehabilitation of surgically treated DRFs combined with an unsupervised home exercise program. A total of 42 participants will be randomly allocated into two groups. The Control Group will undergo the standard surgical procedure, perform the prescribed home exercises recommended by the hospital service, and use an inactive LED plate (photobiomodulation device). The PBM Group will follow the same surgical and exercise protocols but will use an active PBM device. Home exercises will begin 24 hours after surgery and should be performed twice daily for a total of 12 weeks. The device will be applied once daily to the wrist for 12 minutes (6 minutes on the dorsal side and 6 minutes on the palmar side). The primary outcome will be functional wrist assessment using the QuickDASH (Quick Disabilities of the Arm, Shoulder, and Hand) questionnaire at 2 weeks. Secondary outcomes will include wrist range of motion, grip strength, wrist function, and pain (assessed using the PRWE-BR instrument), as well as fracture healing. Assessments will be performed at 2, 4, 6, and 12 weeks post-surgery, except for bone consolidation (assessed starting at week 4) and for pain and range of motion, which will also be evaluated at 24 hours.

Read the detailed description

Distal radius fracture (DRF) is one of the most common fractures in adults. Its treatment can be either conservative or surgical; however, regardless of the treatment method, it is often associated with pain, loss of function and grip strength, joint stiffness, prolonged absence from work, and even loss of fracture reduction. This double-blind, randomized controlled clinical trial aims to evaluate the adjuvant effect of home-based photobiomodulation (PBM) therapy on the rehabilitation of surgically treated DRFs combined with an unsupervised home exercise program. A total of 42 participants will be randomly allocated into two groups (1:1 ratio). The Control Group will undergo the standard surgical procedure, perform the prescribed home exercises recommended by the hospital service, and use an inactive LED plate (photobiomodulation device). The PBM Group will follow the same surgical and exercise protocols but will use an active PBM device. Home exercises will begin 24 hours after surgery and should be performed twice daily for a total of 12 weeks. The LED plate will contain 100 light-emitting diodes, distributed as follows: 18 LEDs at 630 nm (23 mW; 117 J/cm²; 8 J per LED); 18 LEDs at 680 nm (20 mW; 102 J/cm²; 7 J per LED); 32 LEDs at 760 nm (24 mW; 122 J/cm²; 9 J per LED); and 32 LEDs at 830 nm (28 mW; 143 J/cm²; 10 J per LED). The device will be applied once daily to the wrist for 12 minutes (6 minutes on the dorsal side and 6 minutes on the palmar side). The primary outcome will be functional wrist assessment using the QuickDASH (Quick Disabilities of the Arm, Shoulder, and Hand) questionnaire at two weeks. Secondary outcomes will include wrist range of motion, grip strength, wrist function, and pain (assessed using the PRWE-BR instrument), as well as fracture healing. Participants will be blinded to their group allocation and will be evaluated by four researchers who are also blinded to the allocation. Assessments will be performed at 2, 4, 6, and 12 weeks post-surgery, except for bone consolidation (assessed starting at week 4) and for pain and range of motion, which will also be evaluated at 24 hours. In addition to these scheduled assessments, each participant will be followed up with daily phone contact. All collected data will be stored and organized in a secure repository, and appropriate statistical tests will be applied for each specific analysis. A significance level of 5% will be adopted for all tests.

02

Conditions studied

  • Distal Radius Fracture

Browse trials for

Keywords

  • photobiomodulation
  • distal radius
  • locked volar plate
  • early mobility
03

In context

Wrist Fractures

331 studies on the registry are indexed under Wrist Fractures; 71 are open to participants now.

This study's planned enrollment of 42 is below the median of 64 across 266 interventional studies indexed under Wrist Fractures.

Browse Wrist Fractures studies →

Lead sponsor

University of Nove de Julho is the lead sponsor of 246 studies on the registry; 52 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 1 (13%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 65 years,
  • Both sexes,
  • Patients with isolated, closed distal radius fractures with displacement and surgical indication,
  • Surgical indication defined by instability criteria:
  • Dorsal tilt of the distal fragment >20°,
  • Radial shortening ≥10 mm,
  • Articular incongruity,
  • Dorsal comminution,
  • Fractures classified as Fernandez types I, II, or III,
  • Fractures classified as AO/OTA types 2R3A2, 2R3A3, 2R3B, or 2R3C (except 2R3C3).

Exclusion criteria

Exclusion criteria:

  • Previous wrist injuries, sequelae, or motor deficits due to neurological lesions,
  • Pathological fractures,
  • Ipsilateral fractures in other regions of the limb,
  • Neurovascular injury with sensory deficit at the fracture site,
  • Local or systemic to surgery or postoperative recovery,
  • History of photosensitivity,
  • Neurological and/or psychiatric disorders,
  • Proliferative or infectious skin lesions at the wrist region,
  • Pregnancy,
  • Surgical complications (neurological or vascular injuries, or fracture line extension) - excluded from analysis but reported.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
42 participants (estimated)

Study arms

  • Active comparator
    Active photobiomodulation

    Active photobiomodulation wrist brace containing 100 LEDs * 18 LEDs at 630 nm (23 mW; 117 J/cm²; 8 J per LED) * 18 LEDs at 680 nm (20 mW; 102 J/cm²; 7 J per LED) * 32 LEDs at 760 nm (24 mW; 122 J/cm²; 9 J per LED) * 32 LEDs at 830 nm (28 mW; 143 J/cm²; 10 J per LED)

    Procedure: Open reduction and internal fixation (ORIF) with locked volar plate · Procedure: Home exercises · Device: Active photobiomodulation

  • Sham comparator
    Inactive photobiomodulation

    Inactive LED wrist plate, identical in appearance and sound but without active LEDs

    Procedure: Open reduction and internal fixation (ORIF) with locked volar plate · Procedure: Home exercises · Device: Inactive photobiomodulation

Interventions

  • ProcedureOpen reduction and internal fixation (ORIF) with locked volar plate

    All participants will undergo open reduction and internal fixation (ORIF) with a locked volar plate, without postoperative immobilization.

  • ProcedureHome exercises

    Unsupervised protocol twice daily for 12 weeks, starting 24 hours post-surgery

  • DeviceActive photobiomodulation

    The intervention consists of an active photobiomodulation wrist brace equipped with 100 light-emitting diodes (LEDs), including 18 LEDs at 630 nm delivering 23 mW of power, 117 J/cm², and 8 J per LED; 18 LEDs at 680 nm delivering 20 mW of power, 102 J/cm², and 7 J per LED; 32 LEDs at 760 nm delivering 24 mW of power, 122 J/cm², and 9 J per LED; and 32 LEDs at 830 nm delivering 28 mW of power, 143 J/cm², and 10 J per LED. The device will be applied once daily for a total of 12 minutes, with six minutes directed to the dorsal aspect of the wrist and six minutes to the volar aspect, over a 12-week period.

  • DeviceInactive photobiomodulation

    The intervention consists of an inactive LED wrist plate that is identical in appearance and sound to the active device but contains no active LEDs. It will be applied once daily for 12 minutes, during which the device will emit only activation light and sound, without delivering therapeutic irradiation.

06

What researchers measure

Primary outcomes

  1. Quick-DASH functional scale - 2 weeks

    In this project, the disability/symptom component of the QuickDASH (Disabilities of the Arm, Shoulder and Hand) score, validated for Brazil and available online (https://dash.iwh.on.ca/sites/dash/public/translations/Scoring\_QuickDASH\_Portuguese\_Brazil.pdf ), will be used as presented in Appendix 2. The calculation of the Disability/Symptom Score will follow the official instructions provided by the developers. At least 10 of the 11 items must be answered, and each item has a maximum value of 5. The total score is then transformed to a 0-100 scale by subtracting 1 from the mean of the responses and multiplying the result by 25, a procedure that allows comparison with other scales standardized on a 0-100 range. In this context, higher scores indicate greater disability, and the QuickDASH score is therefore expressed according to the following formula: \[(Sum of responses / n) -1\] X 25, where n: number of questions answered

    Time frame: up to 2 weeks

Secondary outcomes

  1. Quick-DASH functional scale - 4 weeks

    In this project, the disability/symptom component of the QuickDASH (Disabilities of the Arm, Shoulder and Hand) score, validated for Brazil and available online (https://dash.iwh.on.ca/sites/dash/public/translations/Scoring\_QuickDASH\_Portuguese\_Brazil.pdf ), will be used as presented in Appendix 2. The calculation of the Disability/Symptom Score will follow the official instructions provided by the developers. At least 10 of the 11 items must be answered, and each item has a maximum value of 5. The total score is then transformed to a 0-100 scale by subtracting 1 from the mean of the responses and multiplying the result by 25, a procedure that allows comparison with other scales standardized on a 0-100 range. In this context, higher scores indicate greater disability, and the QuickDASH score is therefore expressed according to the following formula: \[(Sum of responses / n) -1\] X 25, where n: number of questions answered

    Time frame: up to 4 weeks

  2. Quick-DASH functional scale - 6 weeks

    In this project, the disability/symptom component of the QuickDASH (Disabilities of the Arm, Shoulder and Hand) score, validated for Brazil and available online (https://dash.iwh.on.ca/sites/dash/public/translations/Scoring\_QuickDASH\_Portuguese\_Brazil.pdf ), will be used as presented in Appendix 2. The calculation of the Disability/Symptom Score will follow the official instructions provided by the developers. At least 10 of the 11 items must be answered, and each item has a maximum value of 5. The total score is then transformed to a 0-100 scale by subtracting 1 from the mean of the responses and multiplying the result by 25, a procedure that allows comparison with other scales standardized on a 0-100 range. In this context, higher scores indicate greater disability, and the QuickDASH score is therefore expressed according to the following formula: \[(Sum of responses / n) -1\] X 25, where n: number of questions answered

    Time frame: up to 6 weeks

  3. Quick-DASH functional scale - 12 weeks

    In this project, the disability/symptom component of the QuickDASH (Disabilities of the Arm, Shoulder and Hand) score, validated for Brazil and available online (https://dash.iwh.on.ca/sites/dash/public/translations/Scoring\_QuickDASH\_Portuguese\_Brazil.pdf ), will be used as presented in Appendix 2. The calculation of the Disability/Symptom Score will follow the official instructions provided by the developers. At least 10 of the 11 items must be answered, and each item has a maximum value of 5. The total score is then transformed to a 0-100 scale by subtracting 1 from the mean of the responses and multiplying the result by 25, a procedure that allows comparison with other scales standardized on a 0-100 range. In this context, higher scores indicate greater disability, and the QuickDASH score is therefore expressed according to the following formula: \[(Sum of responses / n) -1\] X 25, where n: number of questions answered

    Time frame: up to 12 weeks

  4. Pain - 24 hours

    Spontaneous pain intensity will be assessed using a 10-cm visual analog scale (VAS) with numerical, color, and facial expression indicators (mild, moderate, severe) to facilitate participant understanding. Pain occurrence will also be recorded during daily monitoring and documented in the participant's control sheet.

    Time frame: up to 24 hours

  5. Pain - 2 weeks

    Spontaneous pain intensity will be assessed using a 10-cm visual analog scale (VAS) with numerical, color, and facial expression indicators (mild, moderate, severe) to facilitate participant understanding. Pain occurrence will also be recorded during daily monitoring and documented in the participant's control sheet.

    Time frame: up to 2 weeks

  6. Pain - 4 weeks

    Spontaneous pain intensity will be assessed using a 10-cm visual analog scale (VAS) with numerical, color, and facial expression indicators (mild, moderate, severe) to facilitate participant understanding. Pain occurrence will also be recorded during daily monitoring and documented in the participant's control sheet.

    Time frame: up to 4 weeks

  7. Pain - 6 weeks

    Spontaneous pain intensity will be assessed using a 10-cm visual analog scale (VAS) with numerical, color, and facial expression indicators (mild, moderate, severe) to facilitate participant understanding. Pain occurrence will also be recorded during daily monitoring and documented in the participant's control sheet.

    Time frame: up to 6 weeks

  8. Pain - 12 weeks

    Spontaneous pain intensity will be assessed using a 10-cm visual analog scale (VAS) with numerical, color, and facial expression indicators (mild, moderate, severe) to facilitate participant understanding. Pain occurrence will also be recorded during daily monitoring and documented in the participant's control sheet.

    Time frame: up to 12 weeks

  9. Analgesic consumption - 2 weeks

    Type and dosage of analgesics, as well as daily use or non-use, will be recorded in the participant's control sheet.

    Time frame: up to 2 weeks

  10. Analgesic consumption - 4 weeks

    Type and dosage of analgesics, as well as daily use or non-use, will be recorded in the participant's control sheet.

    Time frame: up to 4 weeks

  11. Analgesic consumption - 6 weeks

    Type and dosage of analgesics, as well as daily use or non-use, will be recorded in the participant's control sheet.

    Time frame: up to 6 weeks

  12. Analgesic consumption - 12 weeks

    Type and dosage of analgesics, as well as daily use or non-use, will be recorded in the participant's control sheet.

    Time frame: up to 12 weeks

  13. PRWE-BR Questionnaire - Pain and Disability - 2 weeks

    In the PRWE-BR questionnaire, the 15 items are scored from 0 to 10, covering two domains: pain and disability. The pain domain score is obtained by summing the responses to the five corresponding items, whereas the functional domain score is calculated by summing the responses to the ten corresponding items and subsequently dividing the result by two. The total score ranges from 0 to 100, with each domain having a maximum of 50 points. Higher scores indicate greater levels of dysfunction and pain reported by the participant.

    Time frame: up to 2 weeks

  14. PRWE-BR Questionnaire - Pain and Disability - 4 weeks

    In the PRWE-BR questionnaire, the 15 items are scored from 0 to 10, covering two domains: pain and disability. The pain domain score is obtained by summing the responses to the five corresponding items, whereas the functional domain score is calculated by summing the responses to the ten corresponding items and subsequently dividing the result by two. The total score ranges from 0 to 100, with each domain having a maximum of 50 points. Higher scores indicate greater levels of dysfunction and pain reported by the participant.

    Time frame: up to 4 weeks

  15. PRWE-BR Questionnaire - Pain and Disability - 6 weeks

    In the PRWE-BR questionnaire, the 15 items are scored from 0 to 10, covering two domains: pain and disability. The pain domain score is obtained by summing the responses to the five corresponding items, whereas the functional domain score is calculated by summing the responses to the ten corresponding items and subsequently dividing the result by two. The total score ranges from 0 to 100, with each domain having a maximum of 50 points. Higher scores indicate greater levels of dysfunction and pain reported by the participant.

    Time frame: up to 6 weeks

  16. PRWE-BR Questionnaire - Pain and Disability - 12 weeks

    In the PRWE-BR questionnaire, the 15 items are scored from 0 to 10, covering two domains: pain and disability. The pain domain score is obtained by summing the responses to the five corresponding items, whereas the functional domain score is calculated by summing the responses to the ten corresponding items and subsequently dividing the result by two. The total score ranges from 0 to 100, with each domain having a maximum of 50 points. Higher scores indicate greater levels of dysfunction and pain reported by the participant.

    Time frame: up to 12 weeks

  17. Range of Motion -24 hours

    Passive wrist range of motion will be assessed bilaterally using a fleximeter (Sanny, model FL 6010, SBC, São Paulo, Brazil). The evaluator will record the maximum tolerated position for flexion, extension, radial and ulnar deviation, pronation, and supination. For each movement, three measurements will be performed and the mean value will be calculated.

    Time frame: up to 24 hours

  18. Range of Motion - 2 weeks

    Passive wrist range of motion will be assessed bilaterally using a fleximeter (Sanny, model FL 6010, SBC, São Paulo, Brazil). The evaluator will record the maximum tolerated position for flexion, extension, radial and ulnar deviation, pronation, and supination. For each movement, three measurements will be performed and the mean value will be calculated.

    Time frame: up to 2 weeks

  19. Range of Motion - 4 weeks

    Passive wrist range of motion will be assessed bilaterally using a fleximeter (Sanny, model FL 6010, SBC, São Paulo, Brazil). The evaluator will record the maximum tolerated position for flexion, extension, radial and ulnar deviation, pronation, and supination. For each movement, three measurements will be performed and the mean value will be calculated..

    Time frame: up to 4 weeks

  20. Range of Motion - 6 weeks

    Passive wrist range of motion will be assessed bilaterally using a fleximeter (Sanny, model FL 6010, SBC, São Paulo, Brazil). The evaluator will record the maximum tolerated position for flexion, extension, radial and ulnar deviation, pronation, and supination. For each movement, three measurements will be performed and the mean value will be calculated..

    Time frame: up to 6 weeks

  21. Range of Motion - 12 weeks

    Passive wrist range of motion will be assessed bilaterally using a fleximeter (Sanny, model FL 6010, SBC, São Paulo, Brazil). The evaluator will record the maximum tolerated position for flexion, extension, radial and ulnar deviation, pronation, and supination. For each movement, three measurements will be performed and the mean value will be calculated.

    Time frame: up to 12 weeks

  22. Grip Strength - 2 weeks

    Grip strength will be assessed using a digital dynamometer (Instrutherm, model DM-90, São Paulo, Brazil). Participants will be seated with elbows flexed at 90°, forearms neutral, and wrists in slight extension. Three measurements will be performed per limb at each session, alternating between injured and uninjured sides, with a 30-second rest. If the third attempt is the highest, further trials will be added until values decrease. The mean of the three highest values per limb will be recorded as grip strength. For right-dominant limbs, a 10% adjustment will be applied.

    Time frame: up to 12 weeks

  23. Grip Strength - 4 weeks

    Grip strength will be assessed using a digital dynamometer (Instrutherm, model DM-90, São Paulo, Brazil). Participants will be seated with elbows flexed at 90°, forearms neutral, and wrists in slight extension. Three measurements will be performed per limb at each session, alternating between injured and uninjured sides, with a 30-second rest. If the third attempt is the highest, further trials will be added until values decrease. The mean of the three highest values per limb will be recorded as grip strength. For right-dominant limbs, a 10% adjustment will be applied.

    Time frame: up to 4 weeks

  24. Grip Strength - 6 weeks

    Grip strength will be assessed using a digital dynamometer (Instrutherm, model DM-90, São Paulo, Brazil). Participants will be seated with elbows flexed at 90°, forearms neutral, and wrists in slight extension. Three measurements will be performed per limb at each session, alternating between injured and uninjured sides, with a 30-second rest. If the third attempt is the highest, further trials will be added until values decrease. The mean of the three highest values per limb will be recorded as grip strength. For right-dominant limbs, a 10% adjustment will be applied.

    Time frame: up to 6 weeks

  25. Grip Strength - 12 weeks

    Grip strength will be assessed using a digital dynamometer (Instrutherm, model DM-90, São Paulo, Brazil). Participants will be seated with elbows flexed at 90°, forearms neutral, and wrists in slight extension. Three measurements will be performed per limb at each session, alternating between injured and uninjured sides, with a 30-second rest. If the third attempt is the highest, further trials will be added until values decrease. The mean of the three highest values per limb will be recorded as grip strength. For right-dominant limbs, a 10% adjustment will be applied.

    Time frame: up to 12 weeks

  26. Fracture Healing- 4 weeks

    Wrist radiographs in posteroanterior, lateral, and oblique views will be obtained at 4, 6, and 12 weeks to assess bone healing, defined as the presence of callus formation bridging three of the four cortices and uniting the main fracture fragments, compared with the immediate postoperative radiograph. At the end of each follow-up visit, participants will receive written instructions regarding the care to be taken in each phase of treatment, along with the date of the next appointment.

    Time frame: up to 4 weeks

  27. Fracture Healing- 6 weeks

    Wrist radiographs in posteroanterior, lateral, and oblique views will be obtained at 4, 6, and 12 weeks to assess bone healing, defined as the presence of callus formation bridging three of the four cortices and uniting the main fracture fragments, compared with the immediate postoperative radiograph. At the end of each follow-up visit, participants will receive written instructions regarding the care to be taken in each phase of treatment, along with the date of the next appointment.

    Time frame: up to 6 weeks

  28. Fracture Healing- 12 weeks

    Wrist radiographs in posteroanterior, lateral, and oblique views will be obtained at 4, 6, and 12 weeks to assess bone healing, defined as the presence of callus formation bridging three of the four cortices and uniting the main fracture fragments, compared with the immediate postoperative radiograph. At the end of each follow-up visit, participants will receive written instructions regarding the care to be taken in each phase of treatment, along with the date of the next appointment.

    Time frame: up to 12 weeks

  29. Costs Related to Procedures

    The costs will be assessed from the perspective of the Brazilian Unified Health System (Sistema Único de Saúde - SUS) as the purchaser of services. Direct costs of the procedures performed during the study period will be considered, including the value of materials used, professional fees, hospital costs, and costs associated with productivity loss due to time away from work. The sources of cost data in Brazilian currency (Real) will include the ComprasNet database, SIGTAP, and the Price Bank of the Ministry of Health. The final analysis of cost-effectiveness and incremental cost will follow the Methodological Guidelines: Economic Evaluation Studies of Health Technologies and the National Policy on Health Technology Management.

    Time frame: up to 12 weeks

07

Study locations

1 of 1 sites recruiting
  • ACN Municipal Hospital
    São Paulo, 03807-230, Brazil
    Recruiting
    • Nilton I Takahashi, MD · Contact+55 11 3394-8030
08

References and documents

Individual participant data

Plan to share: Yes — The collected data will be stored and organized in a repository and appropriate statistical tests will be applied to specific analyses.

Supporting information: Study protocol

Time frame: Data will be shared at study completion

Access criteria: Data will be shared upon request after study completion.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Jul 2027, 22 months after the start.

Of 128 non-industry interventional studies with no phase under Wrist Fractures, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 22 months is close to that.

Counting every sponsor, half of 129 studies reached it within 24 months; a quarter within 16 and three quarters within 50.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 29, 2026: start Jul 2025 → Sep 2025, primary completion Jul 2026 → Jul 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 5, 2025
First posted
Feb 23, 2026
StartActual
Sep 6, 2025was Jul 2025
Primary completionEst.
Jul 30, 2027was Jul 2026
CompletionEst.
Dec 30, 2027was Dec 2026
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jul 1, 2025→Sep 6, 2025
Sep 29, 2026
Primary completion
Jul 30, 2026→Jul 30, 2027
Sep 29, 2026
Study completion
Dec 30, 2026→Dec 30, 2027
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Start date Jul 1, 2025→Sep 6, 2025
    Primary completion Jul 30, 2026→Jul 30, 2027
    Study completion Dec 30, 2026→Dec 30, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07426926
Responsible party
Kristianne Porta Santos Fernandes (PhD, University of Nove de Julho) — Principal investigator
First posted
Feb 23, 2026
Start date
Sep 6, 2025
Primary completion
Jul 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Kristianne PS Fernandes, PhD
Contact
Kristianne Porta <kristianneporta@gmail.com>
+551133859287
Kristianne PS Fernandes, PhD
study director · University of Nove de Julho

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion